Author: BusinessWire

January 24, 2022 Off

Bio-Thera Solutions Announces First Patient Dosed in Australia for BAT6021, an ADCC-enhanced Monoclonal Antibody Targeting TIGIT for the Treatment of Solid Tumors

GUANGZHOU, China–(BUSINESS WIRE)–#AUSTRALIA–Bio-Thera Solutions, Ltd. (SH: 688177), a commercial-stage pharmaceutical company, today announced that dosing has begun in Phase 1…

January 24, 2022 Off

Greenwich LifeSciences to Implement Stock Repurchase Program for up to $10 Million & to Extend Lock-up of Insiders for an Additional 1 Year

By BusinessWire

STAFFORD, Texas–(BUSINESS WIRE)–Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the “Company”), a clinical-stage biopharmaceutical company focused on the development of GLSI-100, an…

January 24, 2022 Off

BeiGene Announces Positive Findings from Phase 3 Trial of Tislelizumab in Combination with Chemotherapy in First-Line Gastric or Gastroesophageal Junction Cancer

By BusinessWire

In the RATIONALE 305 trial, tislelizumab combined with chemotherapy prolonged overall survival for patients with PD-L1 expression Additional follow-up is…

January 24, 2022 Off

Beckley Psytech Announces First Cohort of Psychotherapists Have Begun Training for Treatment Resistant Depression Phase 2 Trials

By BusinessWire

Training programme to be conducted in partnership with industry-leading educational company, Fluence Initiation of training represents key step to incorporate…

January 24, 2022 Off

MaaT Pharma Announces Positive Interim Engraftment Data for Oral Formulation MaaT033 Allowing Early Termination of Phase 1b CIMON Study

By BusinessWire

MaaT033 is a high-richness, high-diversity, donor-derived Microbiome Ecosystem Therapy for oral administration Four cohorts have completed the study in the…

January 24, 2022 Off

Health Canada Approves Ipsen’s Sohonos™ (palovarotene capsules) as the First Approved Treatment for Fibrodysplasia Ossificans Progressiva

By BusinessWire

PARIS–(BUSINESS WIRE)–Regulatory News: Ipsen (Euronext: IPN; ADR: IPSEY) today announced the Health Canada approval of Sohonos (palovarotene capsules), an oral…

January 21, 2022 Off

Pfizer and OPKO Provide Update on the Biologics License Application for Somatrogon for Pediatric Growth Hormone Deficiency

By BusinessWire

NEW YORK & MIAMI–(BUSINESS WIRE)–Pfizer Inc. (NYSE: PFE) and OPKO Health, Inc. (NASDAQ: OPK) announced today that the U.S. Food…

January 21, 2022 Off

Global Infection Control Market Analytics and Outlook 2022-2026 – Emergence of Outsourcing Trend Bodes Well for Sterilization Services – ResearchAndMarkets.com

By BusinessWire

DUBLIN–(BUSINESS WIRE)–The “Infection Control – Global Market Trajectory & Analytics” report has been added to ResearchAndMarkets.com’s offering. Global Infection Control…

January 21, 2022 Off

The Worldwide Pharmaceutical Excipients Industry is Expected to Reach $10.6 Billion by 2027 – ResearchAndMarkets.com

By BusinessWire

DUBLIN–(BUSINESS WIRE)–The “Global Pharmaceutical Excipients Market Size, Trends & Growth Opportunity, By product, By Formulations, Region and Forecast to 2027”…

January 21, 2022 Off

Worldwide Antibody Drug Conjugates Industry to 2026 – Growing Geriatric Population is Driving Growth – ResearchAndMarkets.com

By BusinessWire

DUBLIN–(BUSINESS WIRE)–The “Antibody Drug Conjugates Market – Growth, Trends, COVID-19 Impact, and Forecasts (2021 – 2026)” report has been added…